The Impact of Gitelman Syndrome on Cardiovascular Disease: From Physiopathology to Clinical Management

Gitelman syndrome (GS), or congenital hypokalemic hypomagnesemia hypocalciuria with metabolic alkalosis, is a congenital inherited tubulopathy. This tubulopathy is associated with disorders of water-electrolyte homeostasis, such as metabolic alkalosis, hypokalemia, hyponatremia, hypomagnesemia and h...

Full description

Bibliographic Details
Main Authors: Andrea Bezzeccheri, Gianluca Di Giovanni, Martina Belli, Rocco Mollace, Lucy Barone, Massimiliano Macrini, Alessio Di Landro, Saverio Muscoli
Format: Article
Language:English
Published: IMR Press 2022-08-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/23/8/10.31083/j.rcm2308289
_version_ 1811188465595842560
author Andrea Bezzeccheri
Gianluca Di Giovanni
Martina Belli
Rocco Mollace
Lucy Barone
Massimiliano Macrini
Alessio Di Landro
Saverio Muscoli
author_facet Andrea Bezzeccheri
Gianluca Di Giovanni
Martina Belli
Rocco Mollace
Lucy Barone
Massimiliano Macrini
Alessio Di Landro
Saverio Muscoli
author_sort Andrea Bezzeccheri
collection DOAJ
description Gitelman syndrome (GS), or congenital hypokalemic hypomagnesemia hypocalciuria with metabolic alkalosis, is a congenital inherited tubulopathy. This tubulopathy is associated with disorders of water-electrolyte homeostasis, such as metabolic alkalosis, hypokalemia, hyponatremia, hypomagnesemia and hypocalciuria. GS has an autosomal recessive inheritance. The loss-of-function mutation involves the gene that codifies for thiazide-sensitive sodium-chloride co-transporter located in the distal convoluted tubule. The physiopathology of the syndrome is characterized by activation of the renin-angiotensin-aldosterone system (RAAS) with a low plasmatic concentration of angiotensin-II. Despite hyper-activation of RAAS, average or low blood pressure is detected in association with low peripheral resistance and reduced response to vasopressors. Clinical findings are brief episodes of fatigue, syncope, vertigo, ataxia and blurred vision; sudden cardiac death might occur. This review aims to give insight into cardiovascular implications and management of GS.
first_indexed 2024-04-11T14:19:15Z
format Article
id doaj.art-8b816bdd19964bfe8f39b1edb94a720c
institution Directory Open Access Journal
issn 1530-6550
language English
last_indexed 2024-04-11T14:19:15Z
publishDate 2022-08-01
publisher IMR Press
record_format Article
series Reviews in Cardiovascular Medicine
spelling doaj.art-8b816bdd19964bfe8f39b1edb94a720c2022-12-22T04:19:07ZengIMR PressReviews in Cardiovascular Medicine1530-65502022-08-0123828910.31083/j.rcm2308289S1530-6550(22)00649-4The Impact of Gitelman Syndrome on Cardiovascular Disease: From Physiopathology to Clinical ManagementAndrea Bezzeccheri0Gianluca Di Giovanni1Martina Belli2Rocco Mollace3Lucy Barone4Massimiliano Macrini5Alessio Di Landro6Saverio Muscoli7Department of Experimental Medicine, University of Rome “Tor Vergata'', 00133 Rome, ItalyDepartment of Experimental Medicine, University of Rome “Tor Vergata'', 00133 Rome, ItalyDepartment of Experimental Medicine, University of Rome “Tor Vergata'', 00133 Rome, ItalyHumanitas Gavazzeni, 24125 Bergamo, ItalyDivision of Cardiology, Fondazione Policlinico “Tor Vergata'', 00133 Rome, ItalyDivision of Cardiology, Fondazione Policlinico “Tor Vergata'', 00133 Rome, ItalyDivision of Cardiology, Fondazione Policlinico “Tor Vergata'', 00133 Rome, ItalyDivision of Cardiology, Fondazione Policlinico “Tor Vergata'', 00133 Rome, ItalyGitelman syndrome (GS), or congenital hypokalemic hypomagnesemia hypocalciuria with metabolic alkalosis, is a congenital inherited tubulopathy. This tubulopathy is associated with disorders of water-electrolyte homeostasis, such as metabolic alkalosis, hypokalemia, hyponatremia, hypomagnesemia and hypocalciuria. GS has an autosomal recessive inheritance. The loss-of-function mutation involves the gene that codifies for thiazide-sensitive sodium-chloride co-transporter located in the distal convoluted tubule. The physiopathology of the syndrome is characterized by activation of the renin-angiotensin-aldosterone system (RAAS) with a low plasmatic concentration of angiotensin-II. Despite hyper-activation of RAAS, average or low blood pressure is detected in association with low peripheral resistance and reduced response to vasopressors. Clinical findings are brief episodes of fatigue, syncope, vertigo, ataxia and blurred vision; sudden cardiac death might occur. This review aims to give insight into cardiovascular implications and management of GS.https://www.imrpress.com/journal/RCM/23/8/10.31083/j.rcm2308289gitelman syndromesudden cardiac deathmetabolic alkalosishypokalemiahypomagnesemiahypocalciuriaarrhythmiaheart failurehypotension
spellingShingle Andrea Bezzeccheri
Gianluca Di Giovanni
Martina Belli
Rocco Mollace
Lucy Barone
Massimiliano Macrini
Alessio Di Landro
Saverio Muscoli
The Impact of Gitelman Syndrome on Cardiovascular Disease: From Physiopathology to Clinical Management
Reviews in Cardiovascular Medicine
gitelman syndrome
sudden cardiac death
metabolic alkalosis
hypokalemia
hypomagnesemia
hypocalciuria
arrhythmia
heart failure
hypotension
title The Impact of Gitelman Syndrome on Cardiovascular Disease: From Physiopathology to Clinical Management
title_full The Impact of Gitelman Syndrome on Cardiovascular Disease: From Physiopathology to Clinical Management
title_fullStr The Impact of Gitelman Syndrome on Cardiovascular Disease: From Physiopathology to Clinical Management
title_full_unstemmed The Impact of Gitelman Syndrome on Cardiovascular Disease: From Physiopathology to Clinical Management
title_short The Impact of Gitelman Syndrome on Cardiovascular Disease: From Physiopathology to Clinical Management
title_sort impact of gitelman syndrome on cardiovascular disease from physiopathology to clinical management
topic gitelman syndrome
sudden cardiac death
metabolic alkalosis
hypokalemia
hypomagnesemia
hypocalciuria
arrhythmia
heart failure
hypotension
url https://www.imrpress.com/journal/RCM/23/8/10.31083/j.rcm2308289
work_keys_str_mv AT andreabezzeccheri theimpactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT gianlucadigiovanni theimpactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT martinabelli theimpactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT roccomollace theimpactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT lucybarone theimpactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT massimilianomacrini theimpactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT alessiodilandro theimpactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT saveriomuscoli theimpactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT andreabezzeccheri impactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT gianlucadigiovanni impactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT martinabelli impactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT roccomollace impactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT lucybarone impactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT massimilianomacrini impactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT alessiodilandro impactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement
AT saveriomuscoli impactofgitelmansyndromeoncardiovasculardiseasefromphysiopathologytoclinicalmanagement